Collective Family Office’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Sell |
2,148
-38
| -2% | -$4.08K | 0.06% | 150 |
|
|
2025
Q1 | $221K | Sell |
2,186
-154
| -7% | -$15.5K | 0.06% | 151 |
|
|
2024
Q4 | $209K | Buy |
+2,340
| New | +$209K | 0.06% | 156 |
|
|
2022
Q3 | – | Sell |
-8,467
| Closed | -$316K | – | 172 |
|
|
2022
Q2 | $316K | Sell |
8,467
-160
| -2% | -$5.97K | 0.14% | 142 |
|
|
2022
Q1 | $382K | Sell |
8,627
-20
| -0.2% | -$886 | 0.15% | 137 |
|
|
2021
Q4 | $367K | Sell |
8,647
-1,000
| -10% | -$42.4K | 0.14% | 134 |
|
|
2021
Q3 | $419K | Sell |
9,647
-1,338
| -12% | -$58.1K | 0.18% | 115 |
|
|
2021
Q2 | $470K | Hold |
10,985
| – | – | 0.2% | 110 |
|
|
2021
Q1 | $425K | Buy |
10,985
+1,310
| +14% | +$50.7K | 0.21% | 117 |
|
|
2020
Q4 | $348K | Buy |
+9,675
| New | +$348K | 0.19% | 119 |
|